seed
Stage
2
Investors
About
Known Medicine uses a machine learning-based sensitivity assay combined with -omics data to analyze patient cancer cells and predict drug responses by building a large 3D cell culture dataset with imaging data.
Explore known medicine's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.